Dr. Liping Liu, having founded HighTide in 2011, brings over 20 years of R&D leadership experience during which she accumulated a wealth of knowledge and perspective in the discovery and development of novel therapies. She is a pioneer in the field of metabolic and digestive diseases with extensive industry experience across the drug development cycle with a track record of leading clinical development for innovative drugs. Dr. Liu is a prolific scientist with over 100 patents and patent applications to her credit. Prior to founding HighTide, Dr. Liu served in leadership positions at various companies including CTL ImmunoTherapies Corporation, MannKind Corporation, Stealth Peptide Inc., and ABLE BioGroup LLC.
Dr. Liu received her bachelor’s degree in chemistry and doctoral degree in physics of polymer from Nankai University, completed post-doctoral training at the University of Toronto, and obtained a master of business administration degree from the Johns Hopkins University Carey Business School.